Rigid nanoparticle-based delivery of anti-cancer siRNA: Challenges and opportunities.

Rigid nanoparticle-based delivery of anti-cancer siRNA: Challenges and opportunities.
Biotechnol Adv. 2013 Sep 4;
Authors: Wang Z, Liu G, Zheng H, Chen X
Abstract
Gene therapy is a promising strategy to treat various genetic and acquired diseases. Small interfering RNA (siRNA) is a revolutionary tool for gene therapy and the analysis of gene function. However, the development of a safe, efficient, and targetable non-viral siRNA delivery system remains a major challenge in gene therapy. An ideal delivery system should be able to encapsulate and protect the siRNA cargo from serum proteins, exhibit target tissue and cell specificity, penetrate the cell membrane, and release its cargo in the desired intracellular compartment. Nanomedicine has the potential to deal with these challenges faced by siRNA delivery. The unique characteristics of rigid nanoparticles mostly inorganic nanoparticles and allotropes of carbon nanomaterials, including high surface area, facile surface modification, controllable size, and excellent magnetic/optical/electrical properties, make them promising candidates for targeted siRNA delivery. In this review, recent progresses on rigid nanoparticle-based siRNA delivery systems will be summarized.
PMID: 24013011 [PubMed - as supplied by publisher]

Source: Biotechnology Advances - September 4, 2013 Category: Biotechnology Authors: Wang Z, Liu G, Zheng H, Chen X Tags: Biotechnol Adv Source Type: research